A novel strategy for production of liraglutide precursor peptide and development of a new long-acting incretin mimic

Nowadays, a small number of incretin mimics are used to treat type 2 diabetes mellitus (T2DM) due to their longer half-life. The present study aimed to introduce a novel method for producing the liraglutide precursor peptide (LPP) and developing a potentially new incretin mimic. Here, human αB-cryst...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmadi, Samaneh, Shahsavani, Mohammad Bagher, Tavaf, Zohreh, Albaghlany, Rawayh Muslim, Kumar, Ashutosh, Moosavi-Movahedi, Ali Akbar, Yousefi, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060347/
https://www.ncbi.nlm.nih.gov/pubmed/35500009
http://dx.doi.org/10.1371/journal.pone.0266833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060347/
https://www.ncbi.nlm.nih.gov/pubmed/35500009
http://dx.doi.org/10.1371/journal.pone.0266833

Ejemplares similares